Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
4.160
+0.090 (2.21%)
Jun 30, 2026, 3:40 PM EDT - Market open
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $53.08 million as of June 30, 2026. Its market cap has increased by 61.36% in one year.
Market Cap
53.08M
Enterprise Value
45.66M
1-Year Change
61.36%
Ranking
Category
Stock Price
$4.16
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has increased from $30.33M to $53.08M, an increase of 75.00%. That is a compound annual growth rate of 9.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 53.08M | 56.62% |
| Dec 31, 2025 | 33.89M | -1.50% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| aTyr Pharma | 55.54M |
| Xilio Therapeutics | 55.46M |
| Boundless Bio | 55.03M |
| Veraxa Biotech AG | 54.72M |
| Impact BioMedical | 54.27M |
| Immutep | 53.74M |
| Context Therapeutics | 53.02M |
| Mereo BioPharma Group | 52.96M |